Hemel Hempstead, UK – An impressive line-up of speakers discussed the unique attributes of hybrid angiography at Heidelberg Engineering’s 5th Annual Masterclass in May. The presentations included a thoughtful and rational look at the role of OCT angiography* in the clinical decision making process as part of a multimodality imaging approach to patient investigation and diagnosis.
Following their presentations, Professor Giovanni Staurenghi, from the University of Milan, alongside new Retina Faculty Chairman, Pearse Keane, NIHR Clinician Scientist at the Institute of Ophthalmology, University College London and Catherine Egan, Consultant Ophthalmologist at Moorfields Eye Hospital took questions from the audience as part of an expert panel discussion.
“OCT angiography is a new imaging tool and we are still in the learning curve” explained Professor Staurenghi. “I think discussing its advantages and pitfalls in a forum such as this is a very honest way to approach this new angiography and we have shown that it is important to exercise caution when using new technology that we do not necessarily fully understand yet. We know that using multimodal imaging provides a better diagnosis than using single imaging modes alone and it seems OCT angiography will play an important role in multimodal imaging in the future”.
The panel agreed that OCT angiography is an exciting new technology with specific clinical applications. However, it was highlighted that there are challenges with image artefact and segmentation that have yet to be overcome by any commercially available device.
A webinar of the Masterclass will be available later in the year. Email Academy-UK@HeidelbergEngineering.com to request to be notified when it is released.
*OCT Angiography for SPECTRALIS is under development and not currently for sale.